Mega Contracts Monitor ($100M+) — July 03, 2026

The 10-year, $900M firm-fixed-price contract aligns with U.S. policy to reduce reliance on foreign nuclear fuel, providing a predictable $90M annual revenue stream for this small business. The contract is a direct beneficiary of bipartisan energy security legislation.

This massive $3.52B contract from HHS, though defense-funded, represents a dominant revenue win for RAPID DEPLOYMENT INC. The size and sole-source nature (implied by lack of competition data) suggest a strong competitive moat in rapid deployment services.

The firm-fixed-price structure on a complex, high-containment laboratory construction project (2026-2030) exposes the joint venture to potential cost overruns. The competitive award suggests pricing pressure, and the JV structure complicates direct revenue attribution to publicly traded parents.

The cost-plus-fixed-fee contract with NASA Ames ends November 2024, with limited remaining revenue runway. KBR must win a follow-on or extension to maintain this revenue stream, creating near-term uncertainty.

AMERICAN CENTRIFUGE OPERATING, a small business, must manage $90M annual fixed-price execution on a novel HALEU production process. Cost overruns could materially impact margins.

MANHATTAN TORCON JV's $491.8M firm-fixed-price contract for a CDC high-containment lab carries high construction risk, especially given specialized biosafety requirements. Change orders or delays could erode profitability.

KBR's $364.7M NASA contract ends November 2024. If not renewed or extended, KBR loses ~$38.6M annual revenue from this specific award. NASA's overall R&D budget for Ames is a key driver.

The digest shows heavy concentration in civilian agencies: HHS ($3.5B + $491.8M), DOE ($900M), Commerce ($606.7M), NASA ($364.7M). Only 1 of 5 contracts is defense-funded, limiting exposure to DOD budget growth.

AMERICAN CENTRIFUGE OPERATING's $900M HALEU contract positions it as a key player in the domestic nuclear fuel supply chain, with potential for follow-on contracts as DOE expands the program.

The $491.8M CDC lab contract signals sustained federal investment in biodefense infrastructure, creating opportunities for construction and engineering firms specializing in high-containment facilities.

Raytheon's $606.7M sole-source award for NOAA's JPSS ground system suggests a strong incumbent position with potential for extensions or follow-on work, despite the cost-plus margin constraints.

Four of five mega-contracts are from civilian agencies (HHS, DOE, Commerce, NASA), totaling $5.48B, focused on physical infrastructure (nuclear fuel, biodefense labs) and IT systems (satellite ground systems). This contrasts with typical defense-heavy mega-contract streams.

The $900M DOE contract to AMERICAN CENTRIFUGE for HALEU production is a direct policy-driven investment to reduce reliance on Russian and foreign nuclear fuel. This aligns with the ADVANCE Act and other bipartisan legislation.

{"entity"=>"AMERICAN CENTRIFUGE OPERATING, LLC", "reason"=>"Won $900M DOE HALEU contract; execution risk on fixed-price structure for a small business.", "trigger"=>"Quarterly DOE progress reports; any contract modifications or cost-sharing adjustments"}

{"entity"=>"MANHATTAN TORCON A JOINT VENTURE", "reason"=>"Won $491.8M CDC lab construction; high fixed-price execution risk on complex project.", "trigger"=>"Contract modifications or change orders; construction milestones through May 2030"}

{"entity"=>"KBR, Inc.", "reason"=>"NASA contract expires Nov 2024; renewal risk for $364.7M revenue stream.", "trigger"=>"NASA Ames follow-on contract announcements before Nov 2024"}

{"entity"=>"RAYTHEON COMPANY (RTX Corp)", "reason"=>"Sole-source $606.7M NOAA contract; option exercises and recompetition risk.", "trigger"=>"NOAA option decisions before Oct 2023; recompetition or extension announcements"}